Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
Before receiving folic acid or cyanocobalamin, patients should be assessed for deficiency and appropriate therapy started concurrently
Please note we have a 3-month minimum for subscriptions
Pregnant or breastfeeding people, anyone with active cancer or a recent cancer history, anyone with liver disease, children and teenagers, and anyone with known sleep disorders should avoid 5-Amino-1MQ outside formal research supervision
Rare cases of allergic contact dermatitis have been described with prolonged copper exposure, so persistent or worsening inflammation should prompt discontinuation and medical evaluation
Compare Match intent to evidence Compare expected use cases, evidence strength, and related options before going deeper